HEAD, RLT INTERNATIONAL DRUG PRODUCT OPERATIONS

Summary The Head of International Drug Product Operations provides executive oversight for all International Drug Product facilities Ivrea & Saluggia (Italy), Zaragoza (Spain), Sasayama (Japan) and Haiyan (China) through local manufacturing leaders.
As a key member of the Global RLT Operations Leadership team, this leader will translate Novartis Technical Operations and International Country strategies into actionable plans including the preparation and delivery of capital projects and driving execution through operational excellence, continuous improvement and innovation.
The role is accountable for enhancing efficiency, maintaining cGMP compliance, ensuring regulatory and quality adherence, and optimizing resources across European and Asian drug product sites to deliver reliable, high-quality products to patients.
Additionally, the leader will foster a high-performance culture, developing talent and strengthening organizational capabilities to support future growth.
In addition, this leader will be responsible for the strategic and operational leadership of a Radioligand Therapies (RLT) facility (TBD), ensuring the achievement of key performance objectives in areas such as Production, Safety, Supply, Cost, Quality and People Development.
About the Role Key responsibilities Lead the RLT Drug Product Manufacturing Operations in International markets to achieve the Technical Operations objectives in Safety, Delivery, Cost, Quality and People.
Ensure successful ramp-up of new sites in Japan, China and any future expansions in line with supply and business plans.
Maintain a close collaboration with the International RLT Leaderships Teams, enabling a close partnership between Operations and Commercial functions.
Ensure Novartis remains the industry leader in Europe and Asia by ensuring doses are always delivered on time and in full.
Ensure all European and Asian Drug Product sites are compliant with company policies, safety and CGMP regulations, local procedures, and processes.
Collaborate with other Site Heads to determine processes and procedures, which can be used across sites and where variances are needed to meet the unique needs of each site.
Develop and communicate the sites strategic plans to achieve company short-term and long-term objectives.
Accountable leader to ensure Capital Projects portfolio for International RLT Drug Product are delivered.
Spearhead and sponsor the implementation of new products and technologies at all the European and Asian Drug Product facilities.
Lead the RLT TechOps International Leadership Team comprised of site and functional heads, monitoring team performance to company goals and objectives through use of established metrics, driving cross-site collaboration within their respective functions.
Provide leadership to International sites employees including appropriate direction, mentoring and development opportunities.
Foster a culture where employees feel respected, supported in speaking up and are personally invested in the success of the organization.
Obligatory requirements.
Education.
BSc degree in chemical engineering, chemistry, pharmacy, or related field or equivalent experience.
Minimum 14 years’ experience in the pharmaceutical industry with minimum 8 years of leadership experience, including relevant experience with sterile manufacturing operations.
Must have experience with major Capital Investment Projects and new plants qualification and start-up is highly desirable.
Aseptic experience with In depth knowledge and understanding of cGMPs and relevant experience in supply chain operations.
Demonstrated ability to communicate effectively and inspire a large organization to achieve shared objectives.
Sense of priorities and capacity to work under pressure Enterprise focus and strategic thinking Strong collaboration focuses with experience working in matrix organization.
Ability to synthesize data and summarize outcomes and recommendations.
Fluent English, written and spoken.
Other languages are a plus.
Desirable requirements.
Education/Training in radiochemistry or radiopharmaceuticals is an advantage (preferred)